Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Food Chem Toxicol ; 46(6): 2165-72, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18397819

ABSTRACT

Activation of peroxisome proliferator-activated receptor (PPAR)-alpha by natural and synthetic chemicals induces hepatic hypertrophy. An aqueous extract of Salacia oblonga root (SOW) is an Ayurvedic medicine with anti-diabetic and anti-obesity properties. In the present study, it was found that SOW (100, 300 and 900mg/kg, once daily by oral gavage over a 28 day period) elicited dose-related increases in liver weight (LW) by 1.6%, 13.4% and 42.5%, respectively, and in the ratio of LW to body weight by 8.8%, 16.7% and 40.2%, respectively, in male rats. These effects were less pronounced in females. SOW selectively increased liver mass in male rats but Sudan red staining was not different, which indicates that hepatic lipid accumulation was similar in both genders. However, SOW even at the highest dosage did not influence serum ALT and AST activities in male or female rats. Moreover, SOW was found to activate PPAR-alpha in human hepatoma-derived HepG2 cells, as evidenced by the upregulation of PPAR-alpha and acyl-CoA oxidase mRNA expression. Thus, SOW-dependent PPAR-alpha activation may precede the development of the gender difference in hepatic hypertrophy; this process may be influenced by sex hormone status.


Subject(s)
Liver/pathology , PPAR alpha/agonists , Salacia/chemistry , Acyl Coenzyme A/biosynthesis , Animals , Body Weight/drug effects , Cell Line, Tumor , Data Interpretation, Statistical , Fatty Liver/chemically induced , Fatty Liver/pathology , Female , Gene Expression/drug effects , Humans , Hypertrophy , Liver Neoplasms/pathology , Male , Plant Extracts/toxicity , Plant Roots/chemistry , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Rats , Rats, Sprague-Dawley , Sex Characteristics , Weight Gain/drug effects
2.
Biochem Pharmacol ; 74(4): 623-38, 2007 Aug 15.
Article in English | MEDLINE | ID: mdl-17610847

ABSTRACT

The omega-atracotoxins (omega-ACTX) are a family of arthropod-selective peptide neurotoxins from Australian funnel-web spider venoms (Hexathelidae: Atracinae) that are candidates for development as biopesticides. We isolated a 37-residue insect-selective neurotoxin, omega-ACTX-Ar1a, from the venom of the Sydney funnel-web spider Atrax robustus, with high homology to several previously characterized members of the omega-ACTX-1 family. The peptide induced potent excitatory symptoms, followed by flaccid paralysis leading to death, in acute toxicity tests in house crickets. Using isolated smooth and skeletal nerve-muscle preparations, the toxin was shown to lack overt vertebrate toxicity at concentrations up to 1 microM. To further characterize the target of the omega-ACTXs, voltage-clamp analysis using the whole-cell patch-clamp technique was undertaken using cockroach dorsal unpaired median neurons. It is shown here for the first time that omega-ACTX-Ar1a, and its homolog omega-ACTX-Hv1a from Hadronyche versuta, reversibly block both mid-low- (M-LVA) and high-voltage-activated (HVA) insect calcium channel (Ca(v)) currents. This block occurred in the absence of alterations in the voltage-dependence of Ca(v) channel activation, and was voltage-independent, suggesting that omega-ACTX-1 family toxins are pore blockers rather than gating modifiers. At a concentration of 1 microM omega-ACTX-Ar1a failed to significantly affect global K(v) channel currents. However, 1 microM omega-ACTX-Ar1a caused a modest 18% block of insect Na(v) channel currents, similar to the minor block of Na(v) channels reported for other insect Ca(v) channel blockers such as omega-agatoxin IVA. These findings validate both M-LVA and HVA Ca(v) channels as potential targets for insecticides.


Subject(s)
Calcium Channel Blockers/pharmacology , Calcium Channels/metabolism , Neurotoxins/toxicity , Spider Venoms/toxicity , Amino Acid Sequence , Animals , Calcium Channel Blockers/chemistry , Calcium Channel Blockers/isolation & purification , Chickens , Dose-Response Relationship, Drug , Electrophysiology , Female , Gryllidae/drug effects , Lethal Dose 50 , Male , Molecular Sequence Data , Molecular Weight , Muscle, Skeletal/drug effects , Muscle, Skeletal/innervation , Muscle, Skeletal/physiology , Neurotoxins/chemistry , Neurotoxins/genetics , Periplaneta/drug effects , Rats , Rats, Sprague-Dawley , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Species Specificity , Spider Venoms/chemistry , Spider Venoms/genetics , Spiders , Toxicity Tests/methods , Vas Deferens/drug effects , Vas Deferens/pathology
3.
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi ; 23(4): 748-52, 2006 Aug.
Article in Chinese | MEDLINE | ID: mdl-17002099

ABSTRACT

The main physiological function of respiratory system is exchange of oxygen and carbon dioxide between atmosphere and blood. Its physiological process is closely related with air flow and transport in respiratory airway. This paper studies numerically the inspiratory flows in a two generation and a three generation bronchial airway. The numerical results of the two generation bronchi show that the present computations fit the available experiments very well. For three generation bronchi, no separation appears within the whole airway under normal breathing rate, which is contrary to the occurrence of separation at even low Reynolds number by the previous two dimensional models. Strong secondary flow phenomenon, skew and m-shaped main flow velocity profiles are found in the airways due to geometrical curvature and bifurcation. These increase shear stress acting on the inner wall as well as on the anterior and posterior wall in the bifurcating airways. In the end bronchi of the three generation airway, the mass flow rates in medial and lateral bronchi are unequal, and the mass flow ratio between the medial and the lateral bronchi is 1.2 at the flow conditions considered.


Subject(s)
Bronchi/physiology , Inhalation/physiology , Models, Biological , Bronchi/anatomy & histology , Finite Element Analysis , Humans
4.
Life Sci ; 78(9): 995-1002, 2006 Jan 25.
Article in English | MEDLINE | ID: mdl-16137711

ABSTRACT

Ileus continues to be a common consequence of abdominal surgery, causing significant patient discomfort and often leading to more serious problems. The therapy available is limited, hence, ileus remains an important clinical problem. Activation of inducible nitric oxide synthase (iNOS) directly modulates intestinal dysmotility after bowel manipulation and plays an essential role in initiating intestinal inflammation. Nuclear factor (NF)-kappaB is known to be a critical component of iNOS gene transcriptional activation in response to inflammatory stimuli. Bromelain is a crude extract from the pineapple stem, which is sold as a nutritional supplement to "promote digestive health" and as an anti-inflammatory medication in some developed countries. Here, we have found that oral administration of bromelain improves decrease in defecation in abdominal postoperative rats. Results showed that bromelain increased the wet weight, dry weight, water content and number of fecal pellets in laparotomized plus mechanically manipulated rats, suggesting improvement of postoperative ileus. Furthermore, bromelain treatment inhibited overexpressed iNOS mRNA and restored down-regulated inhibitor kappaBalpha mRNA in the colon of the postoperative rats. From the in vitro experiments, bromelain inhibits lipopolysaccharide (LPS)-induced nitrite overproduction in macrophage cell lines and LPS-induced NF-kappaB luciferase reporter gene expression in RAW264.7 macrophages transfected with NF-kappaB luciferase reporter gene. Thus, our findings suggest that bromelain improves decrease in defecation in postoperative rats, at least in part, by inhibiting colonic iNOS overexpression via NF-kappaB pathway. Our data indicates that bromelain may benefit patients with postoperative ileus.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Bromelains/pharmacology , Colon/enzymology , Defecation/drug effects , Gene Expression Regulation, Enzymologic/drug effects , Nitric Oxide Synthase Type II/biosynthesis , Postoperative Period , Animals , Cholinesterase Inhibitors/pharmacology , Gastrointestinal Motility , Lipopolysaccharides/pharmacology , Luciferases/metabolism , Macrophages/drug effects , NF-kappa B , Neostigmine/pharmacology , Nitric Oxide Synthase Type II/genetics , Nitrites/metabolism , Rats , Serotonin/pharmacology , Tissue Culture Techniques , Transfection
5.
Peptides ; 26(12): 2412-26, 2005 Dec.
Article in English | MEDLINE | ID: mdl-15979762

ABSTRACT

This project identified a novel family of six 66-68 residue peptides from the venom of two Australian funnel-web spiders, Hadronyche sp. 20 and H. infensa: Orchid Beach (Hexathelidae: Atracinae), that appear to undergo N- and/or C-terminal post-translational modifications and conform to an ancestral protein fold. These peptides all show significant amino acid sequence homology to atracotoxin-Hvf17 (ACTX-Hvf17), a non-toxic peptide isolated from the venom of H. versuta, and a variety of AVIT family proteins including mamba intestinal toxin 1 (MIT1) and its mammalian and piscine orthologs prokineticin 1 (PK1) and prokineticin 2 (PK2). These AVIT family proteins target prokineticin receptors involved in the sensitization of nociceptors and gastrointestinal smooth muscle activation. Given their sequence homology to MIT1, we have named these spider venom peptides the MIT-like atracotoxin (ACTX) family. Using isolated rat stomach fundus or guinea-pig ileum organ bath preparations we have shown that the prototypical ACTX-Hvf17, at concentrations up to 1muM, did not stimulate smooth muscle contractility, nor did it inhibit contractions induced by human PK1 (hPK1). The peptide also lacked activity on other isolated smooth muscle preparations including rat aorta. Furthermore, a FLIPR Ca2+ flux assay using HEK293 cells expressing prokineticin receptors showed that ACTX-Hvf17 fails to activate or block hPK1 or hPK2 receptors. Therefore, while the MIT-like ACTX family appears to adopt the ancestral disulfide-directed beta-hairpin protein fold of MIT1, a motif believed to be shared by other AVIT family peptides, variations in the amino acid sequence and surface charge result in a loss of activity on prokineticin receptors.


Subject(s)
Protein Processing, Post-Translational , Spider Venoms/genetics , Spiders/genetics , Amino Acid Sequence , Animals , Calcium Signaling/drug effects , Cell Line , Gastrointestinal Hormones/pharmacology , Humans , Intercellular Signaling Peptides and Proteins , Male , Molecular Sequence Data , Muscle Contraction/drug effects , Muscle, Smooth/cytology , Muscle, Smooth/metabolism , Peptides/genetics , Protein Structure, Tertiary , Rats , Rats, Wistar , Sequence Homology, Amino Acid , Spider Venoms/pharmacology , Vascular Endothelial Growth Factor, Endocrine-Gland-Derived/pharmacology
6.
J Ethnopharmacol ; 99(2): 239-44, 2005 Jun 03.
Article in English | MEDLINE | ID: mdl-15894133

ABSTRACT

Postprandial hyperglycemia plays an important role in the development of type 2 diabetes and has been proposed as an independent risk factor for cardiovascular diseases. The flowering part of Punica granatum Linn. (Punicaceae) (PGF) has been recommended in Unani literature as a remedy for diabetes. We investigated the effect and action mechanism of a methanolic extract from PGF on hyperglycemia in vivo and in vitro. Oral administration of PGF extract markedly lowered plasma glucose levels in non-fasted Zucker diabetic fatty rats (a genetic model of obesity and type 2 diabetes), whereas it had little effect in the fasted animals, suggesting it affected postprandial hyperglycemia in type 2 diabetes. In support of this conclusion the extract was found to markedly inhibit the increase of plasma glucose levels after sucrose loading, but not after glucose loading in mice, and it had no effect on glucose levels in normal mice. In vitro, PGF extract demonstrated a potent inhibitory effect on alpha-glucosidase activity (IC50: 1.8 microg/ml). The inhibition is dependent on the concentration of enzyme and substrate, as well as on the length of pretreatment with the enzyme. These findings strongly suggest that PGF extract improves postprandial hyperglycemia in type 2 diabetes and obesity, at least in part, by inhibiting intestinal alpha-glucosidase activity.


Subject(s)
Diabetes Mellitus, Experimental/prevention & control , Hypoglycemic Agents/pharmacology , Lythraceae , Phytotherapy , Plant Extracts/pharmacology , alpha-Glucosidases/drug effects , Animals , Blood Glucose/drug effects , Diabetes Mellitus, Experimental/enzymology , Dose-Response Relationship, Drug , Flowers , Glycoside Hydrolase Inhibitors , Hypoglycemic Agents/administration & dosage , Hypoglycemic Agents/therapeutic use , Male , Mice , Mice, Inbred Strains , Plant Extracts/administration & dosage , Plant Extracts/therapeutic use , Postprandial Period , Rats , Rats, Zucker
7.
Life Sci ; 75(14): 1735-46, 2004 Aug 20.
Article in English | MEDLINE | ID: mdl-15268973

ABSTRACT

Diabetes has a markedly greater incidence of cardiovascular disease than the non-diabetic population. The heart shows a slowly developing increase in fibrosis in diabetes. Extended cardiac fibrosis results in increased myocardial stiffness, causing ventricular dysfunction and, ultimately, heart failure. Reversal of fibrosis may improve organ function survival. Postprandial hyperglycemia plays an important role in the development of type 2 diabetes and cardiovascular complications, and has been proposed as an independent risk factor for cardiovascular diseases. Salacia oblonga (S.O.) is traditionally used in the prevention and treatment of diabetes. We investigated the effects of its water extract on cardiac fibrosis and hyperglycemia in a genetic model of type 2 diabetes, the obese Zucker rat (OZR). Chronic administration of the extract markedly improved interstitial and perivascular fibrosis in the hearts of the OZR. It also reduced plasma glucose levels in non-fasted OZR, whereas it had little effect in the fasted animals, suggesting inhibition of postprandial hyperglycemia in type 2 diabetic animals, which might play a role in improvement of the cardiac complications of OZR. Furthermore, S.O. markedly suppressed the overexpression of mRNAs encoding transforming growth factor betas 1 and 3 in the OZR heart, which may be an important part of the overall molecular mechanisms. S.O. dose-dependently inhibited the increase of plasma glucose in sucrose-, but not in glucose-loaded mice. S.O. demonstrated a strong inhibition of alpha-glucosidase activity in vitro, which is suggested to contribute to the improvement of postprandial hyperglycemia.


Subject(s)
Celastraceae/chemistry , Endomyocardial Fibrosis/drug therapy , Gene Expression Regulation/drug effects , Hypoglycemia/drug therapy , Plant Extracts/therapeutic use , RNA, Messenger/metabolism , Analysis of Variance , Animals , Blood Glucose/drug effects , Chromatography, High Pressure Liquid , DNA Primers , Disease Models, Animal , Heart Ventricles/pathology , Histological Techniques , Male , Rats , Rats, Zucker , Transforming Growth Factor beta/metabolism , Xanthones/therapeutic use , alpha-Glucosidases/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...